Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Pattern of remyelination in the CNS.
CNS vasculitis in a patient with MS on daclizumab monotherapy.
'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.
Primary Progressive MS evolving from Radiologically Isolated Syndrome.
195 How Well Do Neuroradiologists Predict the Side of Trigeminal Neuralgia?
Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
How integrated are neurology and palliative care services? Results of a multicentre mapping exercise.
WT1 and interferon-β-vitamin D association in MS: a longitudinal study.
Polymorphism in Leptin and Leptin Receptor Genes May Modify Leptin Levels and Represent Risk Factors for Multiple Sclerosis.
Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy.
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion.
Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis.
Use of rituximab in multiple sclerosis: current progress and future perspectives.
UCSF Seminar: "How do we get a myelinated brain? A new model for distribution of oligodendrocytes throughout the developing CNS"
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.
Is No Evidence of Disease Activity a Realistic Goal for Patients With Multiple Sclerosis?
Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio
The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada.
Assessment of cancer risk with β-interferon treatment for multiple sclerosis.
Cognitive Impairment in Multiple Sclerosis: Clinical Manifestation, Neuroimaging Correlates, and Treatment.
The 10th European Congress of Neuropathology
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.
Clinical proteomics of enervated neurons.
Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study.
Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS).

Pages